View Rule

View EO 12866 Meetings Printer-Friendly Version     Download RIN Data in XML
DOJ/DEA RIN: 1117-AA64 Publication ID: Spring 2004 
Title: Chemical Mixtures Containing Gamma-Butyrolactone 
Abstract: In previous rulemakings, DEA made gamma-butyrolactone (GBL) a List I chemical and established thresholds for transactions involving this chemical. DEA has requested information from interested persons in order to establish regulations governing chemical mixtures containing gamma-butyrolactone (GBL), a List I chemical. Currently, all chemical mixtures containing GBL are exempt from regulation. These mixtures will remain exempt until publication of rulemakings regarding chemical mixtures (see RIN 1117-AA31). GBL is used in the illicit manufacture of GHB, a Schedule I controlled substance. Specifically, DEA is seeking information on the types of products containing GBL; the concentration levels of GBL in the product formulations; and the packaging, distribution, use, and commercial availability of these products. This information will help to determine whether there are chemical mixtures containing GBL which should be exempt from the regulations governing listed chemicals. 
Agency: Department of Justice(DOJ)  Priority: Substantive, Nonsignificant 
RIN Status: Previously published in the Unified Agenda Agenda Stage of Rulemaking: Proposed Rule Stage 
Major: No  Unfunded Mandates: No 
CFR Citation: 21 CFR 1310   
Legal Authority: 21 USC 802    21 USC 830    21 USC 871(b)   
Legal Deadline:  None
Timetable:
Action Date FR Cite
ANPRM  07/19/2002  67 FR 47493   
Correction  08/19/2002  67 FR 53842   
Correction  09/05/2002  67 FR 56776   
ANPRM Comment Period End  09/17/2002    
NPRM  10/00/2004    
NPRM Comment Period End  12/00/2004    
Additional Information: DEA-222
Regulatory Flexibility Analysis Required: No  Government Levels Affected: None 
Small Entities Affected: No  Federalism: No 
Included in the Regulatory Plan: No 
Related RINs: Related to 1117-AA31, Related to 1117-AA52 
Agency Contact:
Christine Sannerud
Chief, Drug and Chemical Evaluation Section
Department of Justice
Drug Enforcement Administration
Office of Diversion Control,
Washington, DC 20537
Phone:202 307-7183